A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE)

Complete Title: RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Trial Phase: II/III
Investigator: Elizabeth Loggers

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

Keywords:
  • Sarcoma
  • Desmoid Tumor
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
Pediatric
II/III
Elizabeth Loggers
RG1121676
NCT04871282
RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Sarcoma
Desmoid Tumor